Zai Lab's Partner argenx Secures EU Approval for Vygart in CIDP Treatment
CompanyDrug

Zai Lab’s Partner argenx Secures EU Approval for Vygart in CIDP Treatment

Harbour BioMed and Otsuka Pharma Collaborate Globally on BCMAxCD3 Bispecific T-cell Engager
CompanyDeals

Harbour BioMed and Otsuka Pharma Collaborate Globally on BCMAxCD3 Bispecific T-cell Engager

CanSino Biologics' PCV13i Vaccine Gains NMPA Approval
CompanyDrug

CanSino Biologics’ PCV13i Vaccine Gains NMPA Approval

Zhongsheng Pharma's RAY1225 Enters Phase III Trial for Obesity/Overweight Treatment
CompanyDrug

Zhongsheng Pharma’s RAY1225 Enters Phase III Trial for Obesity/Overweight Treatment

Dizal's Phase III Trial Completes Enrollment for Shuwozhe in EGFR Exon20ins NSCLC
CompanyDrug

Dizal’s Phase III Trial Completes Enrollment for Shuwozhe in EGFR Exon20ins NSCLC

Shanghai Pharmaceuticals Receives Thai FDA Approval for Pregabalin Capsules
CompanyDrug

Shanghai Pharmaceuticals Receives Thai FDA Approval for Pregabalin Capsules

Wantai Biological Launches Phase III Trial for VZV-7D Varicella Vaccine
CompanyDrug

Wantai Biological Launches Phase III Trial for VZV-7D Varicella Vaccine

MSD Initiates IDeate-Prostate01 Phase III Trial of Ifinatamab Deruxtecan for mCRPC
CompanyDrug

MSD Initiates IDeate-Prostate01 Phase III Trial of Ifinatamab Deruxtecan for mCRPC

Changchun BCHT Gains NMPA Approval for BK-01 Adjuvanted Influenza Vaccine
CompanyDrug

Changchun BCHT Gains NMPA Approval for BK-01 Adjuvanted Influenza Vaccine

NMPA's CDE Reports 4,900 Clinical Trial Filings for Innovative Drugs in 2024
CompanyDrug

NMPA’s CDE Reports 4,900 Clinical Trial Filings for Innovative Drugs in 2024

Beijing Science Sun Pharma Inks RMB20M Drug Tech Transfer Pact for NeoAB33 Project
CompanyDeals

Beijing Science Sun Pharma Inks RMB20M Drug Tech Transfer Pact for NeoAB33 Project

CDE Issues New Requirements for IND Applications of Innovative Drugs
CompanyDrug

CDE Issues New Requirements for IND Applications of Innovative Drugs